Open this publication in new window or tab >>Show others...
2022 (English)In: Amyloid: Journal of Protein Folding Disorders, ISSN 1350-6129, E-ISSN 1744-2818, Vol. 29, no 1, p. 8-13Article in journal (Refereed) Published
Abstract [en]
A reliable diagnosis of amyloidosis is usually based on a tissue biopsy. With increasing options for specific treatments of the different amyloid diseases, an exact and valid diagnosis including determination of the biochemical fibril nature is imperative. Biopsy sites as well as amyloid typing principles vary and this paper describes methods employed at some laboratories specialised in amyloidosis in Europe, Japan and USA.
Place, publisher, year, edition, pages
Taylor & FrancisInforma UK Limited, 2022
Keywords
Amyloid, method, immunohistochemistry, mass spectrometry
National Category
Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy)
Identifiers
urn:nbn:se:uu:diva-479423 (URN)10.1080/13506129.2021.1994386 (DOI)000717867500001 ()34766859 (PubMedID)
2022-06-302022-06-302024-12-03Bibliographically approved